We use computational reasoning to decode that logic, integrating thousands of molecular data points to help clinicians anticipate tumor behavior and guide the most precise treatment decisions.

Precision care is possible for every patient: www.genomate.health/company/our-...

Genomate allows clinicians to:
✔️ Anticipate when a mutation might activate alternate RAS signaling
✔️ Consider combination strategies before resistance appears
✔️ Prioritize therapies that match the biology of the patient

If you’re treating a case that doesn’t fit the standard path, let's talk!

The result is better decisions from bench to bedside, and precision therapies reaching patients faster with scientific and clinical confidence.

#ComputationalReasoning #ClinicalValidation #GenomateHealth

Genomate also enables drug developers to design smarter trials, prioritize targets with higher clinical probability, and identify mechanisms of response before entering the clinic.

At Genomate Health, we understand both perspectives. Genomate, our computational reasoning platform, supports oncologists interpret complex molecular profiles with clarity and confidence in daily practice.

For pharma, AI is driving an unprecedented surge of new targets and compounds. The next challenge is accelerating clinical validation, not by adding complexity but by integrating biological reasoning earlier in development.

For oncologists, this means navigating an expanding universe of molecular data, AI-generated insights, and new treatment options, along with the growing challenge of determining what is clinically relevant and reproducible for each patient.

Our results provide strong evidence that knowledge-graph-based computational reasoning enables consistent and reproducible MTA assignments, with the potential to identify patients who are most likely to benefit from precision oncology compared to standard chemotherapy.

In just 10 minutes, he shares:
✅ Why today’s innovations often don’t reach the patients who need them
✅ How computational reasoning can help standardize care across borders
✅ What it takes to make precision oncology truly accessible

Join the event here: www.technologynetworks.com/tn/online-ev...

In this 10-min talk, Dr. Petak explains why today’s cutting-edge molecular diagnostics often fail to reach the patients who need them most and how Genomate’s computational reasoning is changing that by standardizing therapy decisions across cancer centers:
www.technologynetworks.com/tn/online-ev...

See the results: www.genomate.health/publication/...

Here’s what makes Genomate different:
🔍 We alert oncologists to the most important genetic alteration, so they know where to focus first
⚠️ We flag resistance mechanisms, helping avoid therapies likely to fail
🎯 We optimize for maximum clinical benefit, going beyond matching drugs to mutations